Clinical Trial: Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07477782) titled 'Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation' on March 12.

Brief Summary: Primary Sclerosing Cholangitis (PSC) is a rare cholestatic liver disease, commonly associated with inflammatory bowel disease (IBD) The aim of the present trial is to assess the efficacy of fecal microbiota transplantation (FMT) on ALP and bilirubin compared to sham transplantation in addition to ursodeoxycholic acid (UDCA) treatment in PSC patients.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Primary Sclerosing Cholangitis (PSC) Inflammatory Bowel Disease (IBD)

I...